Marvell Technology, Inc. (MRVL) NASDAQ
90.79
-0.79(-0.86%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
90.79
-0.79(-0.86%)
Currency In USD
| Previous Close | 91.58 |
| Open | 92.11 |
| Day High | 93.44 |
| Day Low | 90.35 |
| 52-Week High | 102.77 |
| 52-Week Low | 47.09 |
| Volume | 11.59M |
| Average Volume | 16M |
| Market Cap | 79.38B |
| PE | 29.57 |
| EPS | 3.07 |
| Moving Average 50 Days | 82.17 |
| Moving Average 200 Days | 79.91 |
| Change | -0.79 |
Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite
Newsfile
Dec 22, 2025 7:07 PM GMT
Toronto, Ontario--(Newsfile Corp. - December 22, 2025) - Rod Matheson, Chief Executive Officer, and Mark Williams, Chief Strategy Officer, from Marvel Biosciences Corp. (the "Company") (TSXV: MRVL), shares the Company's story in an interview with TMX